Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 504

1.

Impact of ventricular tachycardia ablation on health care utilization.

Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber DJ.

Heart Rhythm. 2017 Oct 10. pii: S1547-5271(17)31202-X. doi: 10.1016/j.hrthm.2017.10.009. [Epub ahead of print]

PMID:
29030235
2.

Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases.

Banks H, Torbica A, Valzania C, Varabyova Y, Prevolnik Rupel V, Taylor RS, Hunger T, Walker S, Boriani G, Fattore G; MedtecHTA group.

Europace. 2017 Jun 14. doi: 10.1093/europace/eux123. [Epub ahead of print]

PMID:
29016747
3.

Achieving high-quality care: a view from NICE.

Leng G, Partridge G.

Heart. 2018 Jan;104(1):10-15. doi: 10.1136/heartjnl-2016-311028. Epub 2017 Sep 14. Review.

PMID:
28912290
4.

Evidence of Cognitive Bias in Decision Making Around Implantable-Cardioverter Defibrillators: A Qualitative Framework Analysis.

Matlock DD, Jones J, Nowels CT, Jenkins A, Allen LA, Kutner JS.

J Card Fail. 2017 Nov;23(11):794-799. doi: 10.1016/j.cardfail.2017.03.008. Epub 2017 Mar 28.

PMID:
28363805
5.

Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.

Pokorney SD, Mi X, Hammill BG, Allen LaPointe NM, Curtis LH, Al-Khatib SM.

Am J Cardiol. 2017 May 1;119(9):1401-1406. doi: 10.1016/j.amjcard.2017.01.030. Epub 2017 Feb 10.

PMID:
28341360
6.

Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.

Gold MR, Padhiar A, Mealing S, Sidhu MK, Tsintzos SI, Abraham WT.

JACC Heart Fail. 2017 Mar;5(3):204-212. doi: 10.1016/j.jchf.2016.10.014. Epub 2017 Jan 11.

7.

Improving Clinical Outcomes for Patients With Class III Heart Failure.

Shapiro M, Bires AM, Waterstram-Rich K, Cline TW.

Crit Care Nurs Q. 2017 Apr/Jun;40(2):111-123. doi: 10.1097/CNQ.0000000000000148.

PMID:
28240694
8.

In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan.

Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H.

Heart Vessels. 2017 Aug;32(8):944-951. doi: 10.1007/s00380-017-0958-7. Epub 2017 Feb 23.

PMID:
28233090
9.

Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry.

Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL.

J Am Geriatr Soc. 2017 Feb;65(2):340-347. doi: 10.1111/jgs.14520. Epub 2016 Nov 7.

PMID:
28198561
10.

Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks.

Turakhia MP, Zweibel S, Swain AL, Mollenkopf SA, Reynolds MR.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e002210. doi: 10.1161/CIRCOUTCOMES.115.002210.

PMID:
28196927
11.

The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.

Buchta P, Tajstra M, Kurek A, Skrzypek M, Świetlińska M, Gadula-Gacek E, Wasiak M, Pyka Ł, Gąsior M.

Kardiol Pol. 2017;75(6):573-580. doi: 10.5603/KP.a2017.0019. Epub 2017 Feb 2.

12.

Implantable cardiac devices: the utility of remote monitoring in a paediatric and CHD population.

Olen MM, Dechert-Crooks B.

Cardiol Young. 2017 Jan;27(S1):S143-S146. doi: 10.1017/S1047951116002390. Review.

PMID:
28084972
13.

Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S.

Sridhar AR, Lavu M, Yarlagadda V, Reddy M, Gunda S, Afzal R, Atkins D, Gopinathanair R, Dawn B, Lakkireddy DR.

Pacing Clin Electrophysiol. 2017 Mar;40(3):286-293. doi: 10.1111/pace.13009. Epub 2017 Feb 15.

PMID:
28084622
14.

Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.

Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, Al-Khatib SM, Velazquez EJ, Peterson ED, Wang TY.

Circulation. 2017 Jan 3;135(1):38-47. doi: 10.1161/CIRCULATIONAHA.116.022359. Epub 2016 Nov 16.

PMID:
27881561
15.

A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.

Honarbakhsh S, Providencia R, Srinivasan N, Ahsan S, Lowe M, Rowland E, Hunter RJ, Finlay M, Segal O, Earley MJ, Chow A, Schilling RJ, Lambiase PD.

Int J Cardiol. 2017 Feb 1;228:280-285. doi: 10.1016/j.ijcard.2016.11.017. Epub 2016 Nov 7.

PMID:
27865198
16.

What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population.

Corbisiero R, Buck DC, Muller D, Bharmi R, Dalal N, Kazemian P.

J Interv Card Electrophysiol. 2016 Nov;47(2):189-195. Epub 2016 Sep 9.

PMID:
27613184
17.
18.

The wearable cardioverter-defibrillator: current technology and evolving indications.

Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU; EHRA Scientific Documents Committee (as external reviewers):, Lip G, Gorenek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Blomström-Lundqvist C, Savelieva I.

Europace. 2017 Mar 1;19(3):335-345. doi: 10.1093/europace/euw180. Review.

PMID:
27702851
19.

Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study.

Ricci RP, Vicentini A, D'Onofrio A, Sagone A, Rovaris G, Padeletti L, Morichelli L, Fusco A, De Vivo S, Lombardi L, Denaro A, Pollastrelli A, Colangelo I, Santini M.

Heart Rhythm. 2017 Jan;14(1):50-57. doi: 10.1016/j.hrthm.2016.09.008. Epub 2016 Sep 8.

20.

Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey.

Boveda S, Lenarczyk R, Haugaa K, Fumagalli S, Madrid AH, Defaye P, Broadhurst P, Dagres N.

Europace. 2016 Sep;18(9):1434-9. doi: 10.1093/europace/euw258.

PMID:
27582309

Supplemental Content

Loading ...
Support Center